161 related articles for article (PubMed ID: 7559840)
1. New directions in treating insulin resistance.
Reusch JE
Hosp Pract (1995); 1995 Sep; 30(9):9-10. PubMed ID: 7559840
[No Abstract] [Full Text] [Related]
2. Troglitazone and small low-density lipoprotein in type 2 diabetes.
Hirano T; Yoshino G; Kazumi T
Ann Intern Med; 1998 Jul; 129(2):162-3. PubMed ID: 9669982
[No Abstract] [Full Text] [Related]
3. Troglitazone: a new antihyperglycemic agent.
Vidt DG; Speerhas RA; Reddy SS
Cleve Clin J Med; 1997 May; 64(5):238-40. PubMed ID: 9149473
[TBL] [Abstract][Full Text] [Related]
4. Learning to use troglitazone.
Riddle MC
Diabetes Care; 1998 Sep; 21(9):1389-90. PubMed ID: 9727881
[No Abstract] [Full Text] [Related]
5. New diabetes drug targets insulin resistance.
Am J Health Syst Pharm; 1997 Mar; 54(6):623, 625. PubMed ID: 9075488
[No Abstract] [Full Text] [Related]
6. Efficacy of troglitazone measured by insulin resistance index.
Nagasaka S; Iwamoto Y; Ishikawa S; Kuzuya T; Saito T
Lancet; 1997 Jul; 350(9072):184. PubMed ID: 9250189
[No Abstract] [Full Text] [Related]
7. Effects of troglitazone on insulin sensitivity.
Henry RR
Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
[TBL] [Abstract][Full Text] [Related]
8. Effect of troglitazone on lipoprotein(a) levels in obese subjects.
Tack CJ; Smits P; DeMacker PN; Stalenhoef AF
Diabetes Care; 1999 Oct; 22(10):1752-3. PubMed ID: 10526754
[No Abstract] [Full Text] [Related]
9. New therapeutic approaches to reversing insulin resistance.
Sonnenberg GE; Kotchen TA
Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):551-5. PubMed ID: 9818203
[TBL] [Abstract][Full Text] [Related]
10. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
Westerbacka J; Yki-Järvinen H
Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
[No Abstract] [Full Text] [Related]
11. [Cardiovascular effects of the thiazolidinedione troglitazone].
Yamada K; Kuzuya H; Nakano T
Nihon Rinsho; 2000 Feb; 58(2):435-9. PubMed ID: 10707572
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
Krentz AJ; Bailey CJ; Melander A
BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
[No Abstract] [Full Text] [Related]
13. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
Blonde L; Sandberg MI; Guthrie RD
Diabetes Care; 1999 Jun; 22(6):1004-6. PubMed ID: 10372262
[No Abstract] [Full Text] [Related]
14. The role of troglitazone in treating the insulin resistance syndrome.
Granberry MC; Schneider EF; Fonseca VA
Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309
[TBL] [Abstract][Full Text] [Related]
15. "Glitazones", a prospect for non-insulin-dependent diabetes.
Petrie J; Small M; Connell J
Lancet; 1997 Jan; 349(9045):70-1. PubMed ID: 8996411
[No Abstract] [Full Text] [Related]
16. [Thiazolidinediones].
Scheen AJ; Paquot N; Letiexhe MR; Lefèbvre PJ
Journ Annu Diabetol Hotel Dieu; 1999; ():213-29. PubMed ID: 10732419
[No Abstract] [Full Text] [Related]
17. [A 75-year-old type 2 diabetes mellitus case responding strikingly troglitazone: possible mechanism of insulin resistance induced by insulin antibody].
Takahashi S; Oida K; Miyamori I
Nihon Ronen Igakkai Zasshi; 2000 Apr; 37(4):344-8. PubMed ID: 10917034
[TBL] [Abstract][Full Text] [Related]
18. Surgical and chemical approaches to regulate hyperinsulinemia after pancreas transplantation in rats.
Uchiyama K; Nakai I; Mitsuo M; Shimizu Y; Oka T; Takata Y; Kobayashi M
Transplant Proc; 1998 Mar; 30(2):631-2. PubMed ID: 9532206
[No Abstract] [Full Text] [Related]
19. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J
N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656
[TBL] [Abstract][Full Text] [Related]
20. Effect of troglitazone in type 2 diabetes mellitus.
Gorson DM
N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696655
[No Abstract] [Full Text] [Related]
[Next] [New Search]
